Foundation Fighting Blindness Retinal Degeneration Fund Insider Trading

Name: Foundation Fighting Blindness Retinal Degeneration Fund insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Sale of 556,000 IRD shares, $2.76M.

Get alerted when insiders trade IRD

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Latest filings by Foundation Fighting Blindness Retinal Degeneration Fund

Filed	Company	Transaction	Shares	Value
Oct 2, 2026	Opus Genetics, Inc. (IRD)	Sale	556,000	$2.76M
May 20, 2026	Opus Genetics, Inc. (IRD)	Sale	1,700,000	$7.39M
Dec 11, 2025	Opus Genetics, Inc. (IRD)	Sale	4,000,000	$8.60M
May 6, 2025	Opus Genetics, Inc. (IRD)	Conversion	6,927,419	n/a

Loading insider data...